Search clinical trials for: Luteolytic Agents

Total 186533 results

Parc de Salut Mar

Completed

Generation of Biological Samples Positive to Triptorelin for Anti-doping Control (TRIPTO)

Healthy Volunteers

Spain
Universitaire Ziekenhuizen KU Leuven
Ipsen

Recruiting

Long-term Better Than Short-term ADT With Salvage RT (LOBSTER)

Prostate Cancer

Belgium
Kaunas University of Medicine

Unknown

Investigation of Early Hormonotherapy Efficacy of Prostate Cancer

Prostate Cancer

Lithuania
Ipsen

Completed

A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty.

Central Precocious Puberty

China
Regina Elena Cancer Institute

Recruiting

Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer (STUNNIN)

Prostate Cancer

Italy
Ipsen

Completed

Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study (DECAPUB)

Precocious Puberty

France
Chenshiling
National Natural Science Foundation of China; Comprehensive Strategic Cooperation... and other collaborators

Unknown

Repeated Injection of GnRH Agonist to Reduce Ovarian Hyperstimulation Syndrome

Infertility and at High Risk of OHSS

China
Assaf-Harofeh Medical Center

Recruiting

Follicular Challenge Test to Predict Response to GnRH Agonist Triggering

Infertility, Female

Israel
Tampere University Hospital

Completed

Luteal Phase Support in Insemination Cycles

Infertility, Female

Finland
Sheba Medical Center

Unknown

GnRH Agonist Triggering Supplemented With Hcg in Women With Poor Ovarian Response

Women With Poor Ovarian Response

Israel
Mansoura University

Recruiting

GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles

Infertility

Egypt
American University of Beirut Medical Center

Completed

The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies

Infertility | Sterility

Lebanon
National University of Malaysia

Completed

Luteal Phase Support In IVF Women Using GnRH Agonist

Luteal Phase Defect | IVF

Malaysia
Armando Santoro, MD

Terminated

Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve

Breast Cancer

Italy
Immune System Regulation AB

Unknown

Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients

HIV-1-infection

Sweden, Germany
Ipsen

Terminated

Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT)

Prostate Cancer

Netherlands
Benha University

Unknown

Early Preparation With Gonadotropin- Releasing Hormon (GnRh) Agonists Injection With Frozen-Thawed Embryo Transfer?

Infertility, Female

Egypt
HaEmek Medical Center, Israel

Completed

Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG

Infertility

Israel
Alphamab Jilin Co., Ltd.

Unknown

Single Dose Recombinant Human Follicle Stimulating Hormone Fc Husion Protein (KN015) in Healthy Volunteers

Infertility, Female

China
Azienda Ospedaliera S. Maria della Misericordia

Completed

GnRH Agonist Pretreatment in Hysteroscopic Myomectomy

Uterine Myoma

Italy
Mansoura University

Recruiting

GnRHa for Luteal Phase Support in GnRH Antagonist Protocol Cycles

Infertility

Egypt
Ipsen

Completed

A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients. (PRIORITI)

Prostate Cancer

China, Russian Federation
Ipsen

Completed

Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer (Triptocare)

Prostate Cancer

Spain, Belgium, Netherlands, France, United Kingdom, Denmark, Latvia, Lithuania, Romania, Italy
Kasr El Aini Hospital

Completed

Comparative Study Between Minidose Long Protocol and Microdose Flare Protocol in Controlled Ovarian Hyperstimulation

Infertility
Debiopharm International SA

Completed

Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer

Prostatic Neoplasm

South Africa
Ipsen

Completed

Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty.

Central Precocious Puberty

China
Ipsen

Completed

Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer (DKP 3M SC)

Prostate Cancer

Poland, Romania, Bulgaria, Latvia, France
V.K.V. American Hospital, Istanbul

Terminated

Single Dose Gonadotropin-releasing Hormone (GnRH) Agonist Administration in the Luteal Phase of GnRH Antagonist Stimulated ICSI-ET Cycles

Infertility

Turkey
Meir Medical Center

Unknown

Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS

Infertility
Ain Shams Maternity Hospital

Unknown

The Influence of AMH on Ovarian Responsiveness to Ovulation Induction With GnRH in Women With PCOS

Infertility
SOLTI Breast Cancer Research Group

Recruiting

Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer (SOLTI-2104)

Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Premenopausal Breast Cancer

Spain
University of South Florida
National Cancer Institute (NCI)

Terminated

Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer

Breast Cancer | Drug Toxicity | Hormone Changes

United States
Debiopharm International SA

Completed

Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty

Central Precocious Puberty

United States, Chile, Mexico
Ipsen

Terminated

Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer (ANABRAQ)

Prostate Cancer

Spain
Herlev Hospital

Completed

MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism

Fatty Liver | Metabolic Syndrome | Prostate Cancer | Hypogonadism

Denmark
Aljazeera Hospital
Cairo University

Not yet recruiting

Freeze All on Oocyte Maturatin by Gonadotropin Agonist Versus Human Chorionic Gonadotroipin

Infertility

Egypt
Instituto de Investigacion Sanitaria La Fe

Completed

The Effect of Pre-treatment With GnRH Analogues Prior in Vitro Fertilization in Patients With Endometriosis (ENDOFIV)

Infertility | Endometriosis

Spain
Chenshiling
National Natural Science Foundation of China; Comprehensive Strategic Cooperation... and other collaborators

Unknown

Dual Trigger to Reduce Ovarian Hyperstimulation Syndrome

Infertility and at High Risk of OHSS

China
Hopital Foch

Recruiting

Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis (DECATEC)

Endometriosis | Adenomyosis | Infertility, Female

France
Centre Hospitalier Universitaire Ibn Rochd

Completed

GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Bolus of GnRHa at the Time of Implantation - a RCT (GTMLPSGI)

Infertility

Algeria
Universitair Ziekenhuis Brussel

Completed

Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol

Infertility | Poor Ovarian Response

Belgium
Shaare Zedek Medical Center

Unknown

Luteal-Phase GnRH Agonist Administration in Frozen-Thawed IVF Embryo Transfer Cycles

Pregnancy Rate

Israel
Ipsen

Active, not recruiting

Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate

Metastatic Prostate Cancer | Advanced Prostate Cancer | Locally Advanced Prostate Cancer

China
Assistance Publique - Hôpitaux de Paris

Unknown

Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer (PRESOV)

Sarcoma | Lymphoma | Cancer | Osteosarcoma | Ewing Sarcoma | Toxicity Due to Chemotherapy

France
Elisha Hospital
Merck Sharp & Dohme LLC

Terminated

Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome?

Ovarian Hyperstimulation Syndrome

Israel
Ipsen

Active, not recruiting

Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate (TriptoSwitch)

Prostate Cancer

Spain, Lithuania, Germany, France, Belgium, Netherlands, Czechia
Centre Hospitalier Universitaire Ibn Rochd

Completed

GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT

Infertility

Algeria
Taipei Veterans General Hospital, Taiwan

Unknown

Maintenance Therapy of Levonorgestrel-releasing Intrauterine System (LNG-IUS) to Prevent the Recurrence of Symptomatic Endometriosis After Conservative Surgery

Endometriosis

Taiwan
Belgian Study Group for Pediatric Endocrinology

Active, not recruiting

A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height (ZomaTrip)

Idiopathic Short Stature

Belgium
Debiopharm International SA
Quintiles, Inc.

Completed

Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer

Prostate Cancer

South Africa

3

Subscribe